Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who were 26 years old or younger at the time of their first CAR T-cell treatment
- People who received a CAR T-cell treatment targeting a protein called CD19, used to treat a type of blood cancer called B-cell acute lymphoblastic leukaemia (B-ALL)
- People who received only one type of CAR T-cell product (receiving the same product more than once is allowed)
- People whose cancer went into remission after CAR T-cell treatment and who did not need further treatment afterwards (an exception is made for a stem cell transplant given after the CAR T-cell treatment)
- People who have had no more than one stem cell transplant in total, whether that was before or after their CAR T-cell treatment
- People who are at least 2 years past their last CAR T-cell infusion
Who may not be able to join:
- People who are unable or unwilling to provide written consent, or whose legal guardian or representative is unable or unwilling to do so on their behalf
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Aimee Talleur, MD, St. Jude Children's Research Hospital
Phone: 888-226-4343
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate the feasibility of conducting standardized clinical assessments of pediatric and AYA B-ALL survivors post CD19-CAR T-cell therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.